Delivery Order SPE2DB22D1200-SPE2DB25FN2ET

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,260.76, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,005.10 contract is for the supply of 4,568,093,505 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,821.73, is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery...
This is a $2,081.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, to support federal healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,472.74, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The delivery order has a firm fixed price and an ultimate completion date of April 11, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,788.63, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $3,870.44, is for the supply of 4565668480 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and AmerisourceBergen, which covers the provision of a comprehensive range...
This is a $10,971.06 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for treatment purposes. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a $5,405.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,372.87, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN2ET
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,616.00, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract is not designated as a set-aside and is open to competition. The contract is intended to support military healthcare programs and other government agencies in procuring a wide range of pharmaceutical products and medical supplies.

Generated 8/27/25, 9:52 AM